| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/09/2007 | EP1731530A9 A kind of fusion protein, gene encoding it, expression method and use thereof |
| 05/09/2007 | EP1408941B1 Use of a pharmaceutical composition comprising two quaternary ammonium compounds and an organometallic one in the treatment of viral and fungal infections and diseases |
| 05/09/2007 | EP1319020B1 VARIANTS OF THE MAJOR ALLERGEN Par j 2 OF Paritaria judaica |
| 05/09/2007 | EP1313882B1 Diagnosis and treatment of prostate cancer |
| 05/09/2007 | EP1169058B1 Insulin-like growth factor binding protein-4 protease |
| 05/09/2007 | EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 05/09/2007 | EP1012244B1 Rhabdoviruses with reengineered coats |
| 05/09/2007 | EP0871734B1 Polypeptide fragments capable of competition with streptococcus mutans antigen i/ii |
| 05/09/2007 | EP0793675B9 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/09/2007 | EP0692029B1 Genetically engineered glutaminase and its use in therapy |
| 05/09/2007 | EP0673653B1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 05/09/2007 | CN1961004A Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent |
| 05/09/2007 | CN1961003A Humanized anti-TGF-beta antibodies |
| 05/09/2007 | CN1961002A Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/09/2007 | CN1961001A Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins |
| 05/09/2007 | CN1960767A Potent mucosal immune response induced by modified immunomodulatory oligonucleotides |
| 05/09/2007 | CN1960756A Cytotoxicity mediation of cells evidencing cell membrane surface expression of CD63 |
| 05/09/2007 | CN1960755A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 05/09/2007 | CN1960754A Cancer regulation antibody |
| 05/09/2007 | CN1960753A Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis |
| 05/09/2007 | CN1960752A Medical uses of carrier conjugates of non-human TNF-peptides |
| 05/09/2007 | CN1960751A Vaccine compositions obtained from streptomyces |
| 05/09/2007 | CN1960750A Therapeutic use of anti-CS1 antibodies |
| 05/09/2007 | CN1960744A Peptides of il1 beta and tnf alpha and method of treatment using same |
| 05/09/2007 | CN1960730A Treatment with irinotecan and EGFR-inhibitor |
| 05/09/2007 | CN1958615A Antibody of anti human CD20 from human resources functionally, and application |
| 05/09/2007 | CN1958613A Mucinl antibody and usage |
| 05/09/2007 | CN1958612A MUC5AC antibody and usage |
| 05/09/2007 | CN1958611A Mucin antibody in sera, and usage |
| 05/09/2007 | CN1958610A Medication of guiding antibody for anti leukaemia in monocarpotic cellularity |
| 05/09/2007 | CN1958609A Triad high immune immunoglobulin for anti colibacillosis of pigs |
| 05/09/2007 | CN1958608A Method for preparing specificity IgY of anti influenza of birds, and preparation |
| 05/09/2007 | CN1958075A Compsn of anti-blood generating factor contg adeno-associated virus mediation and its application |
| 05/09/2007 | CN1958074A Injectable block copolymer hydrogel of temperature sensibilityú¿epsi ¿C caprolactone - glycolideú®- polyethyleneglycol |
| 05/09/2007 | CN1958072A Immunoglobulin for anti gosling plague |
| 05/09/2007 | CN1958071A Dual high immunity immunoglobulin for anti reproduction of pig and breathing syndrome, second type cirque virus of pig |
| 05/09/2007 | CN1958070A Triple high immunity immunoglobulin for anti transmissible gastroenteritis of pig, epidemic diarrhea of pig, and rotavirus of pig |
| 05/09/2007 | CN1958069A Triple high immunity immunoglobulin for anti swine pest, aujeszkys disease of pig, and parvovirus of pig |
| 05/09/2007 | CN1958068A Immunoglobulin of anti canine distemper in use for dogs, fox, and ermine |
| 05/09/2007 | CN1314803C Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 05/09/2007 | CN1314706C Antigen epitope II of neutrality B cell of chicken IBDV VP2 protein and application thereof |
| 05/09/2007 | CN1314450C Multicomponent vaccines |
| 05/09/2007 | CN1314449C Combined vaccine composed of viral of Japanese b encephalitis and vaccine of brain fever cocci |
| 05/09/2007 | CN1314448C Medical use and medicinal preparation of trichonema in preventing human and animals from diseases by immunologic inadequacy |
| 05/08/2007 | USRE39614 Canine IL-4 immunoregulatory proteins and uses thereof |
| 05/08/2007 | US7214788 Insect inhibitory Bacillus thuringiensis proteins, fusions, and methods of use therefor |
| 05/08/2007 | US7214787 Recombinant vaccine against botulinum neurotoxin |
| 05/08/2007 | US7214784 Protective antigens for the control of Ixodes species infestations |
| 05/08/2007 | US7214775 Method of modulating the activity of functional immune molecules |
| 05/08/2007 | US7214772 Sialoadhesin family member-2 (SAF-2) |
| 05/08/2007 | US7214713 Supplement with anticancer properties with fermentation of carbohydrates with biosynthesis of Penicillum |
| 05/08/2007 | US7214658 Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection |
| 05/08/2007 | US7214524 Marek's disease virus vaccine |
| 05/08/2007 | US7214499 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
| 05/08/2007 | US7214495 Screening method |
| 05/08/2007 | US7214493 For therapy of cancer |
| 05/08/2007 | US7214479 E. coli O157:H7 C1-INH-binding protein and methods of use |
| 05/08/2007 | US7214380 Composition of an allergen that causes Th2-type T cell response in a susceptible individual, Listeria adjuvant, and a pharmaceutically acceptable carrier; treating allergies associated with an established allergen specific Th2-type T cell response |
| 05/08/2007 | US7214376 Methods of inhibiting TNFα in patients with neoplastic disease |
| 05/08/2007 | US7214375 Providing an antibody to suppress the activity of transforming growth factor; contacting the tissue with the anti-TGF- beta antibody that binds to TGF- beta |
| 05/08/2007 | US7214374 12832, a novel human kinase-like molecule and uses thereof |
| 05/08/2007 | US7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 05/08/2007 | CA2302833C Peptides derived from the attachment (g) protein of respiratory syncytial virus |
| 05/08/2007 | CA2293612C Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 05/08/2007 | CA2273824C Mutants of streptococcal toxin c and methods of use |
| 05/08/2007 | CA2137912C Combinatorial polypeptide antigens |
| 05/08/2007 | CA2102918C Genetic vaccine for immunodeficiency viruses |
| 05/03/2007 | WO2007051164A2 Toll like receptor 3 modulators, methods and uses |
| 05/03/2007 | WO2007051036A2 Influenza combinatorial antigen vaccine |
| 05/03/2007 | WO2007051004A2 Conjugate vaccines for non-proteinaceous antigens |
| 05/03/2007 | WO2007050606A2 Detoxified endotoxin vaccine and adjuvant and uses thereof |
| 05/03/2007 | WO2007050405A2 The induction of indoleamine 2,3-dioxygenase in dendritic cells by tlr ligands and uses thereof |
| 05/03/2007 | WO2007050379A2 Preventing bacterial or viral infectivity and composition containing infection preventing additive |
| 05/03/2007 | WO2007050099A2 Recombinant bcg strains with attenuated immunosuppresive properties |
| 05/03/2007 | WO2007049805A1 Synthetic lipopeptide and use thereof for medical purposes |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049770A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 05/03/2007 | WO2007049737A1 Cytotoxic t-cell epitope peptide capable of specifically attacking cell infected with epstein-barr virus |
| 05/03/2007 | WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same |
| 05/03/2007 | WO2007049624A1 Preventives/remedies for cancer |
| 05/03/2007 | WO2007049472A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 05/03/2007 | WO2007049468A1 Cerebral infarction-preventive agent |
| 05/03/2007 | WO2007049281A1 Ache polypeptides, polynucleotides encoding same and compositions and methods of using same |
| 05/03/2007 | WO2007049117A1 A recombinant 12-kda protein useful for the detection of respiratory allergies |
| 05/03/2007 | WO2007049017A2 Agents that bind a target in pulmonary tissue for treating respiratory diseases |
| 05/03/2007 | WO2007048849A1 Fusion proteins that bind effector lymphocytes and target cells |
| 05/03/2007 | WO2007048326A1 Nanometer targeted drug for magneto-thermotherapy of malignant tumors |
| 05/03/2007 | WO2007048202A1 Methods and compositions for modulating wound repair |
| 05/03/2007 | WO2007048186A1 Leukocyte-binding polypeptides and uses thereof |
| 05/03/2007 | WO2007028985A3 Adjuvanted vaccine |
| 05/03/2007 | WO2007027761A3 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 05/03/2007 | WO2007026190A3 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| 05/03/2007 | WO2007025781A3 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 05/03/2007 | WO2007022416A3 Single chain antibodies against beta-amyloid peptide |
| 05/03/2007 | WO2007015841A3 A method for treating preeclampsia |
| 05/03/2007 | WO2007015167A3 Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 05/03/2007 | WO2007011941A3 Human anti-b7rp1 neutralizing antibodies |
| 05/03/2007 | WO2007010399A3 Purified trimeric s protein as vaccine against severe acute respiratory syndrome virus infections |
| 05/03/2007 | WO2007002571A3 Use of an anti c5 complement antibody to treat patients with sickle cell disease |
| 05/03/2007 | WO2006138670A3 Antibody complexes |